InvestorsHub Logo
Followers 89
Posts 14815
Boards Moderated 1
Alias Born 12/29/2002

Re: janice shell post# 1309

Friday, 05/07/2021 9:24:47 AM

Friday, May 07, 2021 9:24:47 AM

Post# of 23082
I think you better re-read my response. (Also, below I list tons of studies showing the effetiveness of hydroxy).

Apparently you are confusing the studies. Here is how to break it down:

1. Studies that are conducted on hospitalized advanced Covid patients -
Hydroxy not effective.

2. Studies that are conducted on those with Covid where the virus has
advanced to serious respiratory infection --
Hydroxy not effective.

3. Hydroxy used upon the onset of Covid (within 1 to 5 days) --
Hydroxy very effective and highly effective in reducing
hospitalizations
.

Here's how and when to use hydroxy effectively:

https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext

Additionally "For over a year now there has been ever growing, extensive, and overwhelming clinical evidence that HCQ, when used within the first five days of symptom onset, produces a sharp and statistically significant reduction in COVID hospitalization and mortality. Adverse cardiac events are not a factor.

By July of 2020, seven controlled, well-conducted clinical studies had been conducted in Brazil (1353 patients); France (425 nursing-home and clinic patients); New Jersey (1,247 outpatients); Andorra (100 long-term care patients); and 7,892 patients across Saudi Arabia. All of these studies used the premise of the early treatment of high-risk mortality COVID outpatients, and all showed 50% or higher reductions in hospitalization and death. Not a single fatal cardiac arrhythmia was attributable to HCQ in over 11,000 outpatient outcomes. 14

In addition, a summary analysis of five randomized controlled clinical trials involving 5,577 patients in the United States and Spain, also found that outpatient use of HCQ for early treatment of COVID-19, significantly reduced the composite of hospitalization and death. 15
Again, adverse cardiac events were not a factor." See https://drstevenhatfill.com/how-a-single-point-failure-destroyed-the-national-pandemic-plan/

Our own government "refused to publish the ground-breaking June 2020 study showing that early HCQ hospital use is associated with a 51% reduction in mortality. These results were quickly reproduced by a Mt Sinai study and by a later Spanish study which showed a 66% reduction in COVID mortality." See https://drstevenhatfill.com/how-a-single-point-failure-destroyed-the-national-pandemic-plan/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.